BNP Paribas cuts Organon stock target to $16, keeps Outperform

BNP Paribas just lowered its price target for Organon’s stock from $18 to $16, but here’s the twist—they’re still sticking with an "Outperform" rating. Basically, they think the stock will do better than the market average, just not as much better as they previously expected.